tiprankstipranks
Advertisement
Advertisement

Privia Health to Report First Quarter 2024 Results on Thursday, May 9

Privia Health to Report First Quarter 2024 Results on Thursday, May 9

ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024.

Claim 55% Off TipRanks

The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company’s Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 9, to discuss the results and management’s outlook for future financial and operational performance.

You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. If you wish to participate in the live conference call, then please go to https://register.vevent.com/register/BIa226cff209a046a0ae8a7711f796fc02 in order to pre-register and obtain your dial-in number and passcode.

About Privia Health

Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. The Privia Platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and the well-being of providers. For more information, visit priviahealth.com.

Contact
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841

Disclaimer & DisclosureReport an Issue

1